Estrogen and Progesterone Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Estrogen and Progesterone Market covers analysis By Type (Natural Progesterone, Synthetic Progesterone, Estrone, Estradiol, Estriol); Mode of Delivery (Injectable, Suspended Form, Oral); Application (Regulation of the Menstrual Cycle, Dysfunctional Uterine Bleeding, Endometrial Cancer, Contraception, Hyperplastic Precursor Lesions, Egg Follicle Stimulation) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00020031
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION



Estrogen is a female reproductive hormone which plays important role in females for developing secondary sexual characteristics such as pubic hairs, breast development. Estrogen has also role in cognitive health, cardiovascular health. Whereas, progesterone is a naturally produced steroid hormone and is secreted by placenta, ovaries etc. Progesterone has an important role in menstruation, reproductive health, and embryogenesis. Low levels and estrogen and progesterone may result in, abdominal pain, breast tenderness. Hence to prevent such condition the estrogen and progesterone hormone therapy is given.

MARKET DYNAMICS



The key market drivers for Estrogen and Progesterone Market are, increasing prevalence of diseases such as, amenorrhea, abnormal uterine bleeding, uterine cancer etc. Moreover, R&D activities by drug companies to develop effective hormone replacement therapies for management of diseases related to reproductive health is also expected to boost market growth. However, lack of awareness among people about presence of such type of therapies is expected to restrain market growth during forecast period.

MARKET SCOPE



The "Estrogen and Progesterone Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Estrogen and Progesterone market with detailed market segmentation by type, mode of delivery and application. The Estrogen and Progesterone Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Estrogen and Progesterone Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION



The Estrogen and Progesterone Market is segmented on the basis of type, mode of delivery and application. On the basis of type the market is segmented as, natural and synthetic progesterone, estrone, estradiol and estriol. On the basis of mode of delivery market is segmented as, injectable, suspended form and oral. And on the basis of application the market is segmented as, regulation of menstrual cycle, dysfunctional uterine bleeding, endometrial cancer, contraception and egg follicle stimulation.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Estrogen and Progesterone Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Estrogen and Progesterone Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Estrogen and Progesterone Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Estrogen and Progesterone Market in these regions.

MARKET PLAYERS



The report covers key developments in the Estrogen and Progesterone Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Estrogen and Progesterone Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Estrogen and Progesterone market in the global market. Below mentioned is the list of few companies engaged in the Estrogen and Progesterone Market.

The report also includes the profiles of key players in Estrogen and Progesterone Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Teva Pharmaceuticals
  •   Pfizer
  •   Noven Pharmaceuticals, Inc.
  •   Dr. Reddy's Laboratories
  •   Estrellas Life Sciences Private Limited
  •   Bionpharma Inc.
  •   Sofgen Pharmaceuticals
  •   Virtus Pharmaceuticals
  •   Blubell Pharma Group Company
  •   Intas Pharmaceuticals Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Estrogen and Progesterone Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Natural Progesterone
  • Synthetic Progesterone
  • Estrone
  • Estradiol
  • Estriol
By Mode of Delivery
  • Injectable
  • Suspended Form
  • Oral
By Application
  • Regulation of the Menstrual Cycle
  • Dysfunctional Uterine Bleeding
  • Endometrial Cancer
  • Contraception
  • Hyperplastic Precursor Lesions
  • Egg Follicle Stimulation
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Teva Pharmaceuticals
  • Pfizer
  • Noven Pharmaceuticals, Inc
  • Dr. Reddy's Laboratories
  • Estrellas Life Sciences Private Limited
  • Bionpharma Inc
  • Sofgen Pharmaceuticals
  • Virtus Pharmaceuticals
  • Blubell Pharma Group Company
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    1. Teva Pharmaceuticals
    2. Pfizer
    3. Noven Pharmaceuticals, Inc
    4. Dr. Reddy's Laboratories
    5. Estrellas Life Sciences Private Limited
    6. Bionpharma Inc
    7. Sofgen Pharmaceuticals
    8. Virtus Pharmaceuticals
    9. Blubell Pharma Group Company
    10. Intas Pharmaceuticals Ltd

    Buy Now